サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1486406

早期毒性試験の世界市場規模調査：技術別、毒性エンドポイント別、エンドユーザー別、地域別予測：2022～2032年

Global Early Toxicity Testing Market Size study, by Technique, by Toxicity Endpoint, by End User and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
早期毒性試験の世界市場規模調査：技術別、毒性エンドポイント別、エンドユーザー別、地域別予測：2022～2032年
出版日: 2024年05月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の早期毒性試験市場は、2023年に約12億1,000万米ドルとなり、予測期間の2024年から2032年には8.53%以上の健全な成長率で成長すると予測されています。

早期毒性試験は、医薬品開発プロセスにおける重要な段階であり、新規化合物や物質の生体に対する潜在的な悪影響を評価することを目的としています。この予備的評価は、安全性の懸念を特定し、その後の研究開発に役立てます。早期毒性試験を実施することで、研究開発は、医薬品候補をさらなる開発段階に進める前に、リスクを軽減し、安全性プロファイルを最適化することができます。世界の早期毒性試験市場は、新興諸国の研究開発重視の高まりと、生命を脅かす疾患に対する革新的な医薬品・技術開拓への投資の増加により、有望な成長を示しています。

糖尿病、がん、心血管障害などの慢性疾患の有病率の増加により、新規で効果的な治療法に対する需要が高まっており、その安全性を確保するために広範な毒性試験が必要となり、世界の早期毒性試験市場の成長を牽引しています。早期毒性試験サービスに対するこのような需要の急増は、消費者の意識と規制当局の監視によって、食品加工と安全性保証の必要性が高まっていることによって、さらに後押しされています。しかし、特に多様な生物と複数のエンドポイントを含む包括的な試験の場合、早期毒性試験に関連する高コストが、特に資金力の乏しい中小企業にとって大きな障壁となっています。さらに、米国FDAや欧州医薬品庁などの機関が定める厳しい規制要件は、新薬の承認プロセスを長期化させ、市場参入の遅れにより世界の早期毒性試験市場の成長を阻害する可能性があります。

早期毒性試験の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、中南米、その他ラテンアメリカです。2023年には、アジア太平洋が最大の地域市場となりました。アジア太平洋は、研究開発（R&D）活動への強力な注力と、日本、韓国、オーストラリアなどの国々におけるセクターの拡大により、早期毒性試験（ETT）業界をリードする態勢を整えています。さらに、中国、インド、日本、韓国を含むアジア太平洋の特定の国々で脳卒中の発生率が増加していることが、ETT産業の成長に拍車をかけています。脳卒中は、脳卒中患者のための新薬や治療法の開発に極めて重要な役割を果たすため、早期毒性試験にとって重要な関心分野です。National Center for Biotechnology Informationによると、2022年3月現在、40歳以上の中国人の脳卒中発症数は3,400万件、有病者数は1,780万人、脳卒中による死亡数は230万人です。一方、北米は2024年から2032年の予測期間で最も急速に成長している地域です。

本レポートに含まれる主な市場プレイヤー

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Charles River Laboratories International Inc.
  • Danaher Corporation
  • Enzo Biochem Inc.
  • Eurofins Scientific SE
  • Evotec A.G.
  • Merck KGaA
  • PerkinElmer Inc.

目次

第1章 世界の早期毒性試験市場の定義と調査の前提条件

  • 調査目的
  • 市場の定義
  • 調査の前提条件
    • 包含事項・除外事項
    • 制限事項
    • 供給サイド分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 推定手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 早期毒性試験の世界市場規模と予測（2022年～2032年）
  • 地域別概要
  • セグメント別概要
    • 技術別
    • 毒性エンドポイント別
    • エンドユーザー別
  • 主要動向
  • 不況の影響
  • アナリストの結論・提言

第3章 早期毒性試験の世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 早期毒性試験の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 早期毒性試験の世界市場規模・予測：技術別、2022～2032年

  • インビボ
  • インビトロ
  • インシリコ

第6章 早期毒性試験の世界市場規模・予測：毒性エンドポイント別、2022～2032年

  • 遺伝子毒性
  • 経皮毒性
  • 皮膚毒性
  • 眼毒性
  • 光毒性
  • その他

第7章 早期毒性試験の世界市場規模・予測：最終用途別、2022～2032年

  • 医薬品産業
  • 化粧品産業
  • 化学産業
  • 食品産業
  • その他

第8章 早期毒性試験の世界市場規模・予測：地域別、2022～2032年

  • 北米の早期毒性試験市場
    • 米国
      • 技術の内訳規模と予測、2022～2032年
      • 毒性エンドポイントの内訳規模と予測、2022～2032年
      • 最終用途の内訳規模と予測、2022～2032年
    • カナダの早期毒性試験市場
  • 欧州の早期毒性試験市場
    • 英国の早期毒性試験市場
    • ドイツの早期毒性試験市場
    • フランスの早期毒性試験市場
    • スペインの早期毒性試験市場
    • イタリアの早期毒性試験市場
    • その他欧州の早期毒性試験市場
  • アジア太平洋の早期毒性試験市場
    • 中国の早期毒性試験市場
    • インドの早期毒性試験市場
    • 日本の早期毒性試験市場
    • オーストラリア早期毒性試験市場
    • 韓国の早期毒性試験市場
    • その他アジア太平洋の早期毒性試験市場
  • ラテンアメリカの早期毒性試験市場
    • ブラジルの早期毒性試験市場
    • メキシコの早期毒性試験市場
    • その他ラテンアメリカの早期毒性試験市場
  • 中東・アフリカの早期毒性試験市場
    • サウジアラビアの早期毒性試験市場
    • 南アフリカの早期毒性試験市場
    • その他中東・アフリカの早期毒性試験市場

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Agilent Technologies Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation
    • Enzo Biochem Inc.
    • Eurofins Scientific SE
    • Evotec A.G.
    • Merck KGaA
    • PerkinElmer Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1.Global Early Toxicity Testing market, report scope
  • TABLE 2.Global Early Toxicity Testing market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3.Global Early Toxicity Testing market estimates & forecasts by Technique 2022-2032 (USD Billion)
  • TABLE 4.Global Early Toxicity Testing market estimates & forecasts by Toxicity Endpoint 2022-2032 (USD Billion)
  • TABLE 5.Global Early Toxicity Testing market estimates & forecasts by End Use 2022-2032 (USD Billion)
  • TABLE 6.Global Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7.Global Early Toxicity Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8.Global Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9.Global Early Toxicity Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10.Global Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11.Global Early Toxicity Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12.Global Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13.Global Early Toxicity Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14.Global Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15.Global Early Toxicity Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16.U.S. Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 17.U.S. Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18.U.S. Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 19.Canada Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 20.Canada Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21.Canada Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 22.UK Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 23.UK Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24.UK Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 25.Germany Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 26.Germany Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27.Germany Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 28.France Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 29.France Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30.France Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 31.Italy Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 32.Italy Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33.Italy Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 34.Spain Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 35.Spain Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36.Spain Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 37.RoE Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 38.RoE Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39.RoE Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 40.China Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 41.China Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42.China Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 43.India Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 44.India Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45.India Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 46.Japan Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 47.Japan Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48.Japan Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 49.Australia Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 50.Australia Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51.Australia Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 52.South Korea Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 53.South Korea Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.South Korea Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 55.
  • TABLE 56.RoAPAC Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 57.RoAPAC Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58.RoAPAC Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 59.Brazil Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 60.Brazil Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61.Brazil Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 62.Mexico Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 63.Mexico Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64.Mexico Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 65.RoLA Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 66.RoLA Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67.RoLA Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 68.Saudi Arabia Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69.Saudi Arabia Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70.Saudi Arabia Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 71.South Africa Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 72.
  • TABLE 73.South Africa Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74.South Africa Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75.RoMEA Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76.RoMEA Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77.RoMEA Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 78.List of secondary sources, used in the study of Global Early Toxicity Testing Market.
  • TABLE 79.List of primary sources, used in the study of Global Early Toxicity Testing Market.
  • TABLE 80.Years considered for the study.
  • TABLE 81.Exchange rates considered.

LIST OF FIGURES

  • FIG 1.Global Early Toxicity Testing market, research methodology
  • FIG 2.Global Early Toxicity Testing market, market estimation techniques
  • FIG 3.Global market size estimates & forecast methods.
  • FIG 4.Global Early Toxicity Testing market, key trends 2023
  • FIG 5.Global Early Toxicity Testing market, growth prospects 2022-2032
  • FIG 6.Global Early Toxicity Testing market, porters 5 force model
  • FIG 7.Global Early Toxicity Testing market, pestel analysis
  • FIG 8.Global Early Toxicity Testing market, value chain analysis
  • FIG 9.Global Early Toxicity Testing market by segment, 2022 & 2032 (USD Billion)
  • FIG 10.Global Early Toxicity Testing market by segment, 2022 & 2032 (USD Billion)
  • FIG 11.Global Early Toxicity Testing market by segment, 2022 & 2032 (USD Billion)
  • FIG 12.Global Early Toxicity Testing market by segment, 2022 & 2032 (USD Billion)
  • FIG 13.Global Early Toxicity Testing market by segment, 2022 & 2032 (USD Billion)
  • FIG 14.Global Early Toxicity Testing market, regional snapshot 2022 & 2032
  • FIG 15.North America Early Toxicity Testing market 2022 & 2032 (USD Billion)
  • FIG 16.Europe Early Toxicity Testing market 2022 & 2032 (USD Billion)
  • FIG 17.Asia pacific Early Toxicity Testing market 2022 & 2032 (USD Billion)
  • FIG 18.Latin America Early Toxicity Testing market 2022 & 2032 (USD Billion)
  • FIG 19.Middle East & Africa Early Toxicity Testing market 2022 & 2032 (USD Billion)
  • FIG 20.Global Early Toxicity Testing market, company market share analysis (2023)
目次

Global Early Toxicity Testing Market is valued at approximately USD 1.21 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.53% over the forecast period 2024-2032. Early toxicity testing is a critical phase in the drug development process, aimed at assessing the potential adverse effects of new compounds or substances on living organisms. This preliminary evaluation helps identify safety concerns and informs subsequent research and development efforts. By conducting early toxicity testing, researchers can mitigate risks and optimize the safety profile of pharmaceutical candidates before advancing them to further stages of development. The Global Early Toxicity Testing Market shows promising growth due to the heightened emphasis of developing countries on R&D and increased investments in innovative drug and technology development for life-threatening diseases.

The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders has heightened the demand for new and efficacious treatments, necessitating extensive toxicological testing to ensure their safety driving the growth of the Global Early Toxicity Testing Market. This surge in demand for early toxicity testing services is further propelled by the rising need for food processing and safety assurance, driven by consumer awareness and regulatory scrutiny. However, the high costs associated with early toxicity testing, particularly for comprehensive studies involving diverse organisms and multiple endpoints, pose a significant barrier, particularly for smaller companies with limited financial resources. Moreover, stringent regulatory requirements set by agencies such as the US FDA and the European Medicines Agency lengthen the approval process for new drugs, potentially impeding Global Early Toxicity Testing Market growth due to delayed market entry.

The key regions considered for the Global Early Toxicity Testing market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, Asia Pacific was the largest regional market. The Asia-Pacific region is poised to lead the Early Toxicity Testing (ETT) industry, driven by its robust focus on Research and Development (R&D) activities and the expanding sector in nations such as Japan, South Korea, and Australia. Furthermore, the increasing incidence of strokes in specific countries within the Asia-Pacific region, including China, India, Japan, and South Korea, is fueling growth in the ETT industry. Stroke represents a critical area of concern for early toxicity testing, as it plays a pivotal role in the development of new drugs and therapies for stroke patients. According to the National Center for Biotechnology Information, as of March 2022, there were 34 million incident cases of stroke, 17.8 million prevalent cases, and 2.3 million deaths from stroke among the Chinese population aged 40 years and older. Whereas, North America is accounted as the fastest growing region over the forecast period of 2024-2032.

Major market player included in this report are:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Charles River Laboratories International Inc.
  • Danaher Corporation
  • Enzo Biochem Inc.
  • Eurofins Scientific SE
  • Evotec A.G.
  • Merck KGaA
  • PerkinElmer Inc.

The detailed segments and sub-segment of the market are explained below:

By Technique

  • In Vivo
  • In Vitro
  • In Silico

By Toxicity Endpoint

  • Genotoxicity
  • Dermal Toxicity
  • Skin Toxicity
  • Ocular Toxicity
  • Phototoxicity
  • Others

By End Use

  • Pharmaceutical Industry
  • Cosmetic Industry
  • Chemical Industry
  • Food Industry
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Early Toxicity Testing Market Definition and Research Assumptions

  • 1.1.Research Objective
  • 1.2.Market Definition
  • 1.3.Research Assumptions
    • 1.3.1.Inclusion & Exclusion
    • 1.3.2.Limitations
    • 1.3.3.Supply Side Analysis
      • 1.3.3.1.Availability
      • 1.3.3.2.Infrastructure
      • 1.3.3.3.Regulatory Environment
      • 1.3.3.4.Market Competition
      • 1.3.3.5.Economic Viability (Consumer's Perspective)
    • 1.3.4.Demand Side Analysis
      • 1.3.4.1.Regulatory frameworks
      • 1.3.4.2.Technological Advancements
      • 1.3.4.3.Environmental Considerations
      • 1.3.4.4.Consumer Awareness & Acceptance
  • 1.4.Estimation Methodology
  • 1.5.Years Considered for the Study
  • 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

  • 2.1.Global Early Toxicity Testing Market Size & Forecast (2022- 2032)
  • 2.2.Regional Summary
  • 2.3.Segmental Summary
    • 2.3.1.By Technique
    • 2.3.2.By Toxicity Endpoint
    • 2.3.3.By End User
  • 2.4.Key Trends
  • 2.5.Recession Impact
  • 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Early Toxicity Testing Market Dynamics

  • 3.1.Market Drivers
  • 3.2.Market Challenges
  • 3.3.Market Opportunities

Chapter 4.Global Early Toxicity Testing Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model
    • 4.1.7.Porter's 5 Force Impact Analysis
  • 4.2.PESTEL Analysis
    • 4.2.1.Political
    • 4.2.2.Economical
    • 4.2.3.Social
    • 4.2.4.Technological
    • 4.2.5.Environmental
    • 4.2.6.Legal
  • 4.3.Top investment opportunity
  • 4.4.Top winning strategies
  • 4.5.Disruptive Trends
  • 4.6.Industry Expert Perspective
  • 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Early Toxicity Testing Market Size & Forecasts by Technique 2022-2032

  • 5.1.In Vivo
  • 5.2.In Vitro
  • 5.3.In Silico

Chapter 6.Global Early Toxicity Testing Market Size & Forecasts by Toxicity Endpoint 2022-2032

  • 6.1.Genotoxicity
  • 6.2.Dermal Toxicity
  • 6.3.Skin Toxicity
  • 6.4.Ocular Toxicity
  • 6.5.Phototoxicity
  • 6.6.Others

Chapter 7.Global Early Toxicity Testing Market Size & Forecasts by End Use 2022-2032

  • 7.1.Pharmaceutical Industry
  • 7.2.Cosmetic Industry
  • 7.3.Chemical Industry
  • 7.4.Food Industry
  • 7.5.Others

Chapter 8.Global Early Toxicity Testing Market Size & Forecasts by Region 2022-2032

  • 8.1.North America Early Toxicity Testing Market
    • 8.1.1.U.S. Early Toxicity Testing Market
      • 8.1.1.1. Technique breakdown size & forecasts, 2022-2032
      • 8.1.1.2.Toxicity Endpoint breakdown size & forecasts, 2022-2032
      • 8.1.1.3.End Use breakdown size & forecasts, 2022-2032
    • 8.1.2.Canada Early Toxicity Testing Market
  • 8.2.Europe Early Toxicity Testing Market
    • 8.2.1.U.K. Early Toxicity Testing Market
    • 8.2.2.Germany Early Toxicity Testing Market
    • 8.2.3.France Early Toxicity Testing Market
    • 8.2.4.Spain Early Toxicity Testing Market
    • 8.2.5.Italy Early Toxicity Testing Market
    • 8.2.6.Rest of Europe Early Toxicity Testing Market
  • 8.3.Asia-Pacific Early Toxicity Testing Market
    • 8.3.1.China Early Toxicity Testing Market
    • 8.3.2.India Early Toxicity Testing Market
    • 8.3.3.Japan Early Toxicity Testing Market
    • 8.3.4.Australia Early Toxicity Testing Market
    • 8.3.5.South Korea Early Toxicity Testing Market
    • 8.3.6.Rest of Asia Pacific Early Toxicity Testing Market
  • 8.4.Latin America Early Toxicity Testing Market
    • 8.4.1.Brazil Early Toxicity Testing Market
    • 8.4.2.Mexico Early Toxicity Testing Market
    • 8.4.3.Rest of Latin America Early Toxicity Testing Market
  • 8.5.Middle East & Africa Early Toxicity Testing Market
    • 8.5.1. Saudi Arabia Early Toxicity Testing Market
    • 8.5.2. South Africa Early Toxicity Testing Market
    • 8.5.3.Rest of Middle East & Africa Early Toxicity Testing Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Agilent Technologies Inc.
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Market Strategies
    • 9.3.2. Bio-Rad Laboratories Inc.
    • 9.3.3.Bruker Corporation
    • 9.3.4.Charles River Laboratories International Inc.
    • 9.3.5.Danaher Corporation
    • 9.3.6.Enzo Biochem Inc.
    • 9.3.7.Eurofins Scientific SE
    • 9.3.8.Evotec A.G.
    • 9.3.9.Merck KGaA
    • 9.3.10.PerkinElmer Inc.

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes